More on TVTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Travere Therapeutics (NQ:TVTX)
Delayed: 56.68 -0.68 (1.19%)
Prev. Close $57.36  
Open$57.95 
52 Wk High$ 
52 Wk Low$ 
Day High$59.09 
Day Low$56.67 
P/E N/A  
EPS$ 
Volume1,663,215 

Friends, Peers and Foes (?): CSL, CSLLY, LGND, ARWR, CELC (more...)

Jul 10, 2026 05:00 PM Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 9, 2026 05:10 PM Form 8-K Travere Therapeutics, For: Jul 06
Jun 25, 2026 07:38 AM Travere Therapeutics (TVTX) PT Raised to $65 at Guggenheim
Jun 22, 2026 04:37 PM Form 4 Travere Therapeutics, For: Jun 22 Filed by: Inrig Jula
Jun 22, 2026 08:09 AM Travere Therapeutics (TVTX) PT Raised to $61 at Wedbush
Jun 17, 2026 04:33 PM Form S-8 Travere Therapeutics,
Jun 16, 2026 04:47 PM Form 4 Travere Therapeutics, For: Jun 12 Filed by: Coughlin Timothy
Jun 16, 2026 04:43 PM Form 4 Travere Therapeutics, For: Jun 12 Filed by: Baynes Roy D.
Jun 16, 2026 04:35 PM Form 8-K Travere Therapeutics, For: Jun 12
Jun 16, 2026 04:30 PM Travere Therapeutics names new R&D head ahead of 2027 retirement
View All Articles

Entities mentioned with TVTX

View All Entities